IL6 and type 2 diabetes mellitus: After drug intervention, BZYQF markedly enhanced the mRNA expression of PKA, IP3R, β1-AR, AQP5, CHRM3, and AMY1 and reduced the mRNA expression of IL-6 and TNF-α in the PG and SMG of T2DM rats.